Sagopilone (ZK-EPO) inhibits bone destruction and tumor burden more efficiently than paclitaxel in a mouse model of established breast cancer bone metastasis

✍ Scribed by Anne Strube; Elizaveta Stepina; Ulrich Klar; Peter Hauff; Jens Hoffmann; Sanna-Maria Käkönen

• Book ID: 116320575
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 59 KB
• Volume: 42
• Category: Article
• ISSN: 8756-3282
• DOI: 10.1016/j.bone.2007.12.210